Sanquin Reagents

Activities: Analysis

Sanquin is responsible for safe and efficient blood supply in the Netherlands on a not-for-profit basis. Sanquin also develops and produces pharmaceutical products, conducts high-quality scientific research, and develops and performs a multitude of diagnostic services

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Analysis

Sanquin to exhibit at PDA Europe

Meet the team to discover its new test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Analysis

Sanquin exhibits at Pharmalab Congress

Sanquin is the first company worldwide to introduce a test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Research & Development

Sanquin contributes to European research against MS

Sanquin researchers Dr Anja ten Brinke and Professor Marieke van Ham take part in a European consortium that aims to find a cure for multiple sclerosis

Reliable and reproducible Monocyte Activation Test

Sanquin Reagents has developed a reliable and reproducible Monocyte Activation Test (MAT), which can replace rabbit testing for measuring endotoxin and non-endotoxin pyrogens

Masterclass on Biologics — towards personalised medicine

27 October | Workshop | Amsterdam, Netherlands

New worldwide exclusive license and collaboration for immuno-oncology therapeutic leads

Synthon Biopharmaceuticals BV, an international biopharmaceutical company that is focused on developing new molecular entities for treating cancer and autoimmune diseases, has announced a new license and collaboration agreement for the development of novel immuno-oncology antibodies with Sanquin Blood Supply Foundation (‘Sanquin’), Amsterdam
Subscribe now